drugset

drugset / Trial / NCT03553615

Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis

NCT03553615 ↗

Phase 2 Withdrawn Stanford University

NaSingle-groupOpen-labelTreatment

Summary

This pilot trial studies how well a novel oral therapeutic agent performs to treat patients with atopic dermatitis, particularly facial dermatitis.

Timeline

Start: 2030-12-01
Primary completion: 2030-12
Completion: 2030-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ivermectin	Small molecule	12 mg	Oral

Indications